---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011475"
form_type: "8-K"
ticker: "TNGX"
cik: "0001819133"
company_name: "Tango Therapeutics, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:52:47.247279+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tango Therapeutics shareholders elect Calhoun and Huber as Class I directors, ratify PwC as auditor

## Summary
- Lesley Ann Calhoun elected with 74,549,730 votes for, 2,532,608 withheld, 4,658,458 broker non-votes.
- Reid Huber elected with 74,547,606 votes for, 2,534,732 withheld, 4,658,458 broker non-votes.
- PricewaterhouseCoopers ratified as independent auditor for FY2022 with 81,737,938 votes for, 400 against, 2,458 abstain.
- Annual meeting held June 8, 2022; 81,740,796 shares represented (93.19% of outstanding).

## SEC filing metadata
- accession: 0000950170-22-011475
- form_type: 8-K
- ticker: TNGX
- cik: 0001819133
- company_name: Tango Therapeutics, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819133/000095017022011475/0000950170-22-011475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819133/000095017022011475/tngx-20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011475
- JSON: https://secwatch.observer/filing/0000950170-22-011475.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011475.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.